Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Neuroendocrine cancer

Closing the GAPP on predicting metastases

Nature Reviews Endocrinology volume 10, pages 315–316 (2014)Cite this article

Subjects

A promising grading system to predict metastasis in patients with phaeochromocytoma and paraganglioma assigns risk according to selected histological and other criteria. Such risk stratification might be useful for personalized management and screening programmes, as it could limit the costs of follow-up and reduce the risk of disseminated disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kimura, N., Watanabe, T., Noshiro, T., Shizawa, S. & Miura, Y. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr. Pathol. 16, 23–32 (2005).

    Article  Google Scholar 

  2. Kimura, N. et al. Pathologic grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr. Relat. Cancer http://dx.doi.org/10.1530/ERC-13-0494.

  3. Thompson, L. D. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am. J. Surg. Pathol. 26, 551–566 (2002).

    Article  Google Scholar 

  4. Ayala-Ramirez, M. et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J. Clin. Endocrinol. Metab. 96, 717–725 (2011).

    Article  CAS  Google Scholar 

  5. Eisenhofer, G., Tischler, A. S. & de Krijger, R. R. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr. Pathol. 23, 4–14 (2012).

    Article  CAS  Google Scholar 

  6. Korevaar, T. I. & Grossman, A. B. Pheochromocytomas and paragangliomas: assessment of malignant potential. Endocrine 40, 354–365 (2011).

    Article  CAS  Google Scholar 

  7. Eisenhofer, G. et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur. J. Cancer 48, 1739–1749 (2012).

    Article  CAS  Google Scholar 

  8. King, K. S. et al. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J. Clin. Oncol. 29, 4137–4142 (2011).

    Article  CAS  Google Scholar 

  9. Wu, D. et al. Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. Am. J. Surg. Pathol. 33, 599–608 (2009).

    Article  Google Scholar 

  10. Mete, O. et al. Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas. Arch. Pathol. Lab. Med. 138, 182–188 (2014).

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the support of Deutsche Forschungsgemeinschaft EI855/1/1, European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 259735 (ENS@T-Cancer).

Author information

Authors and Affiliations

  1. Institute of Clinical Chemistry & Laboratory Medicine and Department of Medicine III, University Hospital, Technische Universität Dresden, Fetscherstrasse 74, Dresden, 01307, Germany

    Graeme Eisenhofer

  2. Department of Pathology, Tufts Medical Center, 800 Washington Street, Boston, 02111, MA, USA

    Arthur S. Tischler

Authors
  1. Graeme Eisenhofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arthur S. Tischler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Graeme Eisenhofer.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisenhofer, G., Tischler, A. Closing the GAPP on predicting metastases. Nat Rev Endocrinol 10, 315–316 (2014). https://doi.org/10.1038/nrendo.2014.41

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2014.41

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer